Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas [Phase 1]
A Phase 1 trial of TLN-121 for relapsed or refractory non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS other · 2026-03-27Clinical Trial Update: Phase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid Malignancies [Phase 1]
Phase 1 basket trial update for cord blood-derived NK cells engineered with IL-15 and TGFBR2 knockout, for relapsed/refractory lymphoid mali…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma [Phase 1]
Phase 1 safety and tolerability study of CFT7455 in relapsed/refractory non-Hodgkin's lymphoma and multiple myeloma is currently active but …
-
CLINICAL_TRIALS other · 2026-03-23Clinical Trial Update: Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study [Phase 2]
Clinical trial HALTAging-1 is a Phase 2 study targeting aging in survivors of blood cancers; the trial is not yet recruiting.
-
EMA approval · 2026-03-20EMA Authorised: Adcetris (Brentuximab vedotin) — Takeda Pharma A/S
EMA authorised Adcetris (brentuximab vedotin) for Hodgkin lymphoma and non-Hodgkin lymphoma, with Takeda Pharma A/S as the marketing authori…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial [Phase 3]
This entry details a Phase 3 extension study of Venetoclax for patients who completed prior Venetoclax trials. The study is currently active…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 ) [Phase 1]
A Phase 1 study of LY4152199 in previously treated B-cell cancers is listed, with the trial currently NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Improving Exercise Capacity With a Tailored Physical Activity Intervention [NA]
This clinical trial update indicates Wake Forest University Health Sciences is recruiting for a tailored physical activity intervention aime…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma [Phase 1]
AstraZeneca reports a Phase 1 clinical trial of AZD0486 in B-cell non-Hodgkin lymphomas, including diffuse large B-cell lymphoma, high-grade…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas [Phase 1]
Phase 1 clinical trial update evaluating radiation therapy, oral vancomycin, and CAR-T cell therapy for large B-cell/Non-Hodgkin lymphoma, c…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A clinical trial is evaluating benefits and harms of cannabis/cannabinoid use among cancer patients treated in community oncology clinics; r…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating CD19 t-haNK and NAI with Rituximab in relapsed indolent non-Hodgkin lymphoma; the study is not yet recru…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating CD79b-19 CAR T cells for relapsed or refractory non-Hodgkin lymphoma, including several subtypes, is cur…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial update on the investigational drug GLPG5101 (19CP02) for Relapsed/Refractory B-cell Non-Hodgkin Lymphoma, with th…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T [Phase 2]
Phase 2 clinical trial evaluating Odronextamab for relapsed or refractory large B-cell lymphomas before CAR-T therapy; the study is currentl…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders [Phase 2]
Phase 2 clinical trial evaluating cord blood transplant in children and young adults with blood cancers and select non-malignant disorders; …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Odronextamab in Low Tumor Volume Advanced FL [Phase 2]
Phase 2 study evaluating odronextamab for low-tumor-volume advanced follicular lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy [Phase 2]
A Phase 2 clinical trial evaluating epcoritamab for patients with follicular lymphoma who did not achieve a complete response to upfront che…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies [Phase 1]
Phase 1 clinical trial update of BGB-21447, a Bcl-2 inhibitor developed by BeOne Medicines, evaluating safety and preliminary activity in mu…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma [Phase 1]
A Phase 1, open-label dose-escalation trial of the CD38-targeted radiopharmaceutical CD38-SADA:177Lu-DOTA Drug Complex in relapsed or refrac…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Long-Term Follow-up Study
Long-term follow-up study of relapsed/refractory non-Hodgkin lymphoma is currently enrolling by invitation, sponsored by Caribou Biosciences…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases [NA]
This entry reports an ongoing clinical trial evaluating myeloablative preparative regimens for umbilical cord blood transplantation across s…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas [Phase 1, Phase 2]
Phase 1/2 study evaluating the combination of lenalidomide with DA-EPOCH-R in MYC-associated B-cell lymphomas has completed, and results hav…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 trial update for ATA3219 in relapsed/refractory B-cell non-Hodgkin lymphoma notes that the study has been terminated, with safety …
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating CMV-MVA Triplex vaccination in HLA-matched related stem cell donors to prevent cytomegalovirus infection i…